Timo Reisländer

2PUBLICATIONS
4CO-AUTHORS
Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 19, 2019
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors.

Timo Reisländer, Emilia Puig Lombardi, Florian J Groelly

|Jul 06, 2019
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.

Eliana Mc Tacconi, Sophie Badie, Giuliana De Gregoriis

Pageof 1